Literature DB >> 16849530

Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis.

Frank Eckerdt1, Klaus Strebhardt.   

Abstract

Polo-like kinase 1 (Plk1) is a key regulator of progression through mitosis. Although Plk1 seems to be dispensable for entry into mitosis, its role in spindle formation and exit from mitosis is crucial. Recent evidence suggests that a major role of Plk1 in exit from mitosis is the regulation of inhibitors of the anaphase-promoting complex/cyclosome (APC/C), such as the early mitotic inhibitor 1 (Emi1) and spindle checkpoint proteins. Thus, Plk1 and the APC/C control mitotic regulators by both phosphorylation and targeted ubiquitylation to ensure the fidelity of chromosome separation at the metaphase to anaphase transition. The mechanisms underlying the control of genomic stability by Plk1 are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849530     DOI: 10.1158/0008-5472.CAN-06-0358

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

Review 1.  Polo-like kinases: conservation and divergence in their functions and regulation.

Authors:  Vincent Archambault; David M Glover
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04       Impact factor: 94.444

2.  Different phosphorylation states of the anaphase promoting complex in response to antimitotic drugs: a quantitative proteomic analysis.

Authors:  Judith A J Steen; Hanno Steen; Ann Georgi; Kenneth Parker; Michael Springer; Marc Kirchner; Fred Hamprecht; Marc W Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-17       Impact factor: 11.205

3.  Phosphorylation of right open reading frame 2 (Rio2) protein kinase by polo-like kinase 1 regulates mitotic progression.

Authors:  Ting Liu; Min Deng; Junhui Li; Xiaomei Tong; Qian Wei; Xin Ye
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

4.  Inferring cell cycle feedback regulation from gene expression data.

Authors:  Fulvia Ferrazzi; Felix B Engel; Erxi Wu; Annie P Moseman; Isaac S Kohane; Riccardo Bellazzi; Marco F Ramoni
Journal:  J Biomed Inform       Date:  2011-02-16       Impact factor: 6.317

Review 5.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

Review 6.  Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer development.

Authors:  Jijing Luo; Xiaoqi Liu
Journal:  Protein Cell       Date:  2012-03-23       Impact factor: 14.870

7.  Quantitative kinase and phosphatase profiling reveal that CDK1 phosphorylates PP2Ac to promote mitotic entry.

Authors:  Isha Nasa; Lauren E Cressey; Thomas Kruse; Emil P T Hertz; Jiang Gui; Lee M Graves; Jakob Nilsson; Arminja N Kettenbach
Journal:  Sci Signal       Date:  2020-09-08       Impact factor: 8.192

8.  Regulation of cell cycle and RNA transcription genes identified by microarray analysis of PC-3 human prostate cancer cells treated with luteolin.

Authors:  Kevin Shoulars; Mary Ann Rodriguez; Trellis Thompson; Barry M Markaverich
Journal:  J Steroid Biochem Mol Biol       Date:  2009-10-27       Impact factor: 4.292

9.  Requirements for protein phosphorylation and the kinase activity of polo-like kinase 1 (Plk1) for the kinetochore function of mitotic arrest deficiency protein 1 (Mad1).

Authors:  Ya-Hui Chi; Kerstin Haller; Michael D Ward; O John Semmes; Yan Li; Kuan-Teh Jeang
Journal:  J Biol Chem       Date:  2008-10-15       Impact factor: 5.157

10.  PLK1 down-regulates parainfluenza virus 5 gene expression.

Authors:  Dengyun Sun; Priya Luthra; Zhuo Li; Biao He
Journal:  PLoS Pathog       Date:  2009-07-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.